LLBO logo

Lifeline Biotechnologies, Inc. Stock Price

OTCPK:LLBO Community·US$3.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

LLBO Share Price Performance

US$0.0007
0.00 (600.00%)
US$0.0007
0.00 (600.00%)
Price US$0.0007

LLBO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Lifeline Biotechnologies, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$574.3k

Other Expenses

-US$574.3k

Earnings

Last Reported Earnings
Dec 31, 2009
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About LLBO

Founded
1981
Employees
n/a
CEO
James Holmes
WebsiteView website
www.lbti.co

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.

Recent LLBO News & Updates

No updates

Recent updates

No updates